Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-03

Clinical Trial Update: Modulation Effects of Baduanjin Exercise on Subjective Cognitive Decline [NA]

View source ↗

Summary

A Massachusetts General Hospital-sponsored trial evaluated whether Baduanjin exercise modulates subjective cognitive decline; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Cognitive Decline | NA | Status: COMPLETED